6PZ3

Polymerase Eta-catalyzed insertion of correct G opposite template cytarabine (AraC) residue

6PZ3 の概要

• エントリーDOI: 10.2210/pdb6pz3/pdb
• 分子名称: DNA polymerase eta, DNA Primer strand, DNA template containing cytarabine (AraC) residue, ... (7 entities in total)
• 機能のキーワード: cytarabin, lesion bypass, dna damage, replication, chemotherapy, transferase
• 由来する生物種: Homo sapiens (Human); 詳細
• タンパク質・核酸の鎖数: 3
• 化学式量合計: 55357.66

構造登録者

Rechkoblit, O.,Aggarwal, A.K. (登録日: 2019-07-31, 公開日: 2019-11-20, 最終更新日: 2024-03-13)

主引用文献

Rechkoblit, O.,Johnson, R.E.,Buku, A.,Prakash, L.,Prakash, S.,Aggarwal, A.K.
Structural insights into mutagenicity of anticancer nucleoside analog cytarabine during replication by DNA polymerase eta.
Sci Rep, 9:16400-16400, 2019

PubMed Abstract: Cytarabine (AraC) is the mainstay chemotherapy for acute myeloid leukemia (AML). Whereas initial treatment with AraC is usually successful, most AML patients tend to relapse, and AraC treatment-induced mutagenesis may contribute to the development of chemo-resistant leukemic clones. We show here that whereas the high-fidelity replicative polymerase Polδ is blocked in the replication of AraC, the lower-fidelity translesion DNA synthesis (TLS) polymerase Polη is proficient, inserting both correct and incorrect nucleotides opposite a template AraC base. Furthermore, we present high-resolution crystal structures of human Polη with a template AraC residue positioned opposite correct (G) and incorrect (A) incoming deoxynucleotides. We show that Polη can accommodate local perturbation caused by the AraC via specific hydrogen bonding and maintain a reaction-ready active site alignment for insertion of both correct and incorrect incoming nucleotides. Taken together, the structures provide a novel basis for the ability of Polη to promote AraC induced mutagenesis in relapsed AML patients.

PubMed: 31704958
DOI: 10.1038/s41598-019-52703-7

実験手法

X-RAY DIFFRACTION (2.395 Å)